Cats Whiskers and Java Tea- diabetes treatment

New Post Public Reply Private Reply Replies (1) Message Board
wowhappens28
233
Cats Whiskers and Java Tea- diabetes treatment

Nutritional analysis PROVES the effectiveness of herbal medicine in treating diabetes


http://www.alternativemedicine.news/2018-07-0...betes.html

It stands to reason that since a lot of drug treatments in Western medicine are rooted from plant-based sources, actual plants that are used as medicine should be considered in the same regard. Of course, that isn’t the case with most medicinal plants, as the same community that has approved its synthetic derivatives for use is the same one blocking herbal medicine from widespread use. Fortunately, there are times where science actually proves that traditional applications of medicinal plants can be verified after a thorough analysis.

Such is the case of cat’s whiskers (Orthosiphon stamineus), a herb used in traditional medicine to treat diabetes, as a study in BMC Complementary and Alternative Medicine has validated this claim using a novel tool to measure anti-diabetic activity. The plant is popular in Southeast Asia, where it’s used to treat a wide range of diseases such as diabetes, hypertension, and even rheumatism. In these areas, it’s consumed as part of a herbal infusion called Java tea, and it’s the second most popular alternative treatment for diabetes, following the bitter gourd.

For a plant that’s known as a potent treatment for diabetes, not a lot of studies have been done to verify this claim. At the time of the study, researchers claimed that their paper was the first of its kind to analyze the anti-diabetic property of cat’s whiskers using a metabolomic approach.

In the study, researchers used extracts derived from the leaves of cat’s whiskers, which were then dissolved in different solvents – namely, water (aqueous), ethanol, equal-part water and ethanol, and methanol. These were then administered to rats that were injected with streptozotocin to mimic the effects of diabetes. During the experiment, which ran for 14 days, rats were fed with their respective extracts. The researchers studied metabolic activity by testing the urine from the samples using the NRM metabolomics approach.

Researchers found that the aqueous extract of cat’s whiskers exhibited anti-diabetes action similar to glibenclamide, a drug which boosts insulin production to reduce glucose in the blood. The extract also contained multiple phytochemicals that have potent antioxidant activity, including rosmarinic acid, protocatechuic acid, caffeic acid, tetramethoxy chalcone derivatives, ferulic acid, syringic acid, kaempferol methyl ether, succinic acid, protocatechuic acid hexoside, and luteolin.

They also identified metabolic pathways that were targeted by the aqueous extract. Of these pathways, cat’s whiskers impacted the pathways that regulate ketone synthesis and degradation – which could be useful in diets such as the ketogenic diet.

“These pathways represent their potential as the targeted pathways of OSAE treatment in diabetic condition,” they added.

All in all, the team found that the herb cat’s whiskers could be a promising agent in diabetes treatment, given its ability to regulate glucose formation, lipid and amino acid build-up, and its effect on various metabolic pathways. “The results of this study validated the ethnopharmacological use of [cat’s whiskers] in diabetes and unveiled the biochemical and metabolic mechanisms involved,” the researchers concluded in their report.

Indeed, many types of medicinal plants are proven to be effective in treating various diseases. With studies like these, it’s not far off to think that more people will consider how potent these cures, despite the industry’s best efforts to put a lid on it. (Related: Turmeric and omega 3s can cure diabetes – but you’ll never hear that from your doctor.)

Buy at Amazon.
https://www.amazon.com/Orthosiphon-Perennial-...B00DPK04ZS
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Regeneron Faces Class Action Over Tumultuous Trial Results

Updated Category News Views 3

Regeneron's Meltdown: A Bitter Pill for Investors Let’s dive headlong into the mess Regeneron Pharmaceuticals (NASDAQ:REGN) finds itself in—a classic nightmare scenario for investors. News broke like an old valve bursting, and suddenly, the market's love for Regeneron ran ice-cold. Who's to blame this time? Well, you might want to point a finger at the failed Phase 3...

Continue Reading
Big Wins at Americas Cardroom's $15M Venom Series

Updated Category News Views 0

High Stakes and Huge Paydays: The Venom Breakdown Alright, folks, here's a tale of how the cards fell in one of the most electrifying poker standoffs at Americas Cardroom. With prize pools clocking in at a staggering $15.095 million, the Dual Mystery Bounty Venoms really stacked the chips high. From the gritty, bustling halls of the internet to the proverbial green-felt...

Continue Reading
Drunk Angel Celebrates First Year in Crystal Jewelry

Updated Category News Views 2

One Year Down, A Unique Path Forward It's been a year since Drunk Angel jumped into the online jewelry scene, and they're setting themselves apart in their own glittery lane. Imagine starting a brand that's not just about pretty trinkets, but about linking those tiny treasures to timeless traditions. They've got their sights set on blending the deep tales of gemstones...

Continue Reading
Celebree Elevates Early Ed with New Certification Push

Updated Category News Views 0

A New Standard in Early Childhood Education In the cutthroat world of childcare and early education, just meeting the state standards ain't cutting it anymore. Celebree School, known for its infant, toddler, and preschool programs, is shaking things up with its 'Celebree Certified' initiative, setting a brand-new benchmark for teacher readiness that's far beyond the usual...

Continue Reading
Lida Group Expands Global Modular Construction Services

Updated Category News Views 5

Modular Construction's Expanding Footprint Behold Lida Group—a titan in the world of modular construction—taking ambitious strides into the global arena, reaching from the sand dunes of Saudi Arabia to the bustling corridors of the United Nations. If you haven't been paying attention, now's the time to get your head in the game. Their expansion isn't just about...

Continue Reading
Jollibee and DreamWorks Unite for Cultural Celebration

Updated Category News Views 1

Jollibee Partners with DreamWorks Animation Never thought I’d see the day: Jollibee, that familiar face of fast food, teaming up with the creative juggernaut DreamWorks Animation. They’re calling it a celebration of friendship and Filipino culture, wrapped up neatly in the context of a flick called Forgotten Island. Set to sizzle in theaters on September 25, 2026,...

Continue Reading
Dentsply Sirona Faces Insider Troubles: An Investor Call

Updated Category News Views 3

Are Dentsply Sirona Insiders on Thin Ice? The stock market's a tumultuous sea, and right now, it seems like some of those at the helm of Dentsply Sirona Inc. might be rocking the boat a bit too much. Let me tell you, navigating these corporate storms isn't for the faint-hearted. The latest noise coming from Halper Sadeh LLC suggests that some directors and officers over...

Continue Reading
DoorDash Speeds Up Gifting: Same-Day Delivery Wins

Updated Category News Views 3

Transforming Urgent Gift-Giving with Local Delivery Ever found yourself scrambling for a last-minute gift when time seems to be slipping away? That's where DoorDash steps up, changing the game with their same-day delivery options. In the fast-paced world we're living in, folks aren't just leaning on DoorDash for takeout anymore. They're pushing it as a lifeline for...

Continue Reading
Supernova SPAC Lawsuit: Settlement Proposed, $3M on Table

Updated Category News Views 3

Legal Clouds Over Supernova's SPAC Adventure Alright, folks, buckle up, because whenever you mix SPACs and lawsuits, you're in for a roller coaster. Supernova Partners Acquisition Company, Inc. stands right at the heart of a class action lawsuit, and it's been cooking ever since the court in Delaware gave it a nudge forward. Settlement Talk: What's on the Table? So here's...

Continue Reading
York Space Systems Faces Investor Lawsuit Over Claims

Updated Category News Views 1

Allegations Stir the Pot: York Space Systems Under Fire Now we're sailing into choppy waters with York Space Systems (YSS). There's a full-blown ruckus stirring as investors take aim at the company, thanks to a class action lawsuit alleging securities fraud. The legal beagles from Glancy Prongay Wolke & Rotter LLP are spearheading this effort, claiming that York pulled...

Continue Reading

Top 5 Most Recently Viewed Articles

Neumora Therapeutics: Upcoming Financial Results and Insights

Updated Category News Views 123

Neumora Therapeutics to Announce Financial Results Neumora Therapeutics, Inc. (Nasdaq: NMRA), a pioneering biopharmaceutical firm, is gearing up to share its financial outcomes for the second quarter of a future year. The conference call is set for 4:30 p.m. ET on a Wednesday, and this event aims to deliver important updates regarding their business and strategic...

Continue Reading
Exciting Insights into Claudin 6 Targeted Therapy for Cancer

Updated Category News Views 165

Introduction to TORL BioTherapeutics and TORL-1-23 TORL BioTherapeutics, LLC is leading the way in developing innovative cancer treatments, particularly focusing on antibody-drug conjugates that target Claudin 6. Their flagship product, TORL-1-23, has shown significant potential in recent clinical trials specifically aimed at patients with Claudin 6 positive cancers. This...

Continue Reading
Understanding Plasma Biomarkers for Liver Health in Youth

Updated Category News Views 118

Plasma Biomarkers and Liver Health in Adolescents Recent research has unveiled an exciting advancement in pediatric medicine regarding liver health in adolescents, particularly among Latino youth facing obesity. The study, conducted by the Children's Hospital Los Angeles, led by Principal Investigator Michael Goran, PhD, has explored the potential of plasma-based...

Continue Reading
Gruma's Market Control: A Look at Price Fixing in Mexico

Updated Category News Views 119

Cofece Ruling on Gruma's Price Fixing Authority In a significant decision that has set the stage for future pricing strategies, Mexico's antitrust authority, Cofece, announced that Gruma, a prominent player in the corn flour and tortilla market, has the ability to fix prices. This conclusion was reached following a comprehensive investigation, which revealed a lack of...

Continue Reading
Coloplast A/S Unveils Strong Financial Performance for 2024/25

Updated Category News Views 190

Coloplast A/S Interim Financial Highlights for 2024/25 Coloplast A/S has recently announced its interim financial results for the period from 1 October 2024 to 30 June 2025. This report unveils the company's impressive organic growth and highlights its strategies for maintaining its market position. Remarkable Growth Figures The latest results showcase an organic growth...

Continue Reading